Winclove Probiotics

Winclove Probiotics, established in Amsterdam, has been specializing in research, development and manufacturing of probiotic formulations since 1991. In close collaboration with business partners, research institutes and university hospitals we develop evidence-based, indication-specific probiotics for a variety of indications. Our probiotic formulations enable people worldwide to improve their health in a natural way.

Coline Gerritsen joins the Board at Winclove Probiotics

04/22/2020

It gives us great pleasure to inform you that our colleague Coline Gerritsen will join the Executive Board at Winclove Probiotics with immediate effect.

Winclove Probiotics: measures on Coronavirus

03/17/2020

As we are all in the grip of the spreading Coronavirus and continuously changing situations, Winclove closely follows the news of COVID-19 and follows very strict the advice of the RIVM (Dutch...

Winclove Statement on concerns on E. COLI NISSLE 1917

02/28/2020

On February 27th 2020 Hans Clevers and his colleagues have published a study in the renowned scientific journal Nature (doi.org/10.1038/s41586-020-2080-8). In this publication their mechanistic...

Implementing probiotics in elderly care

11/26/2019

How can evidence based probiotics, such as Ecologic® AAD, be implemented in elderly care institutes?

Hay fever patients benefit from Ecologic® ALLERGYCARE

05/23/2018

New research from Griffith University and Winclove shows significant benefits of Ecologic® AllergyCare for hay fever patients.

Business Opportunities

Winclove’s mission is to create long-lasting, sustainable and strategic partnerships with customers and to provide them with the distinct competitive advantages that help them succeed in the market